Immune-complex deposits in "pauci-immune" glomerulonephritis: A case report and brief review of recent literature

Archives of Medical Science

Volumn 6, Issue 4, 2010, Pages 633-637

  El Ters, Mireille ^a   Muthyala, Umadevi ^a   Philipneri, Marie D ^a   Hussein, Fadi A ^a   Lentine, Krista L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti neutrophil cytoplasmic antibodies; Glomerulonephritis; Immune deposits

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; MEPREDNISONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

AGED; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; PHYSICAL EXAMINATION; PLASMAPHERESIS; PROSTATECTOMY; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

EID: 77956826709     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.14479     Document Type: Article

References (26)

1. Pettersson EE, Sundelin B, Heigl Z. Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 1995; 43: 141-49.
2. Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004; 65: 2145-52. (Pubitemid 38670000)
3. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 2000; 36: 709-18.
4. Neumann I, Regele H, Kain R, Birck R, Meisl FT. Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant 2003; 18: 524-31.
5. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 1982; 285: 606.
6. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135: 921-30.
7. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-7.
8. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998; 53: 743-53.
9. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-9. (Pubitemid 15173133)
10. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989; 84: 1577-87.
11. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958; 2: 265-70.
12. Fauci AS, Wolff SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973; 52: 535-61.
13. Jayne D, Rasmussen N, Andrassy K, et al.; European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349: 36-44.
14. Sanders JS, Slot MC, Stegeman CA. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349: 2072-3.
15. Little MA, Pusey CD. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol 2004; 17 (Suppl 8): S10-9.
16. Jayne DR, Gaskin G, Rasmussen N, et al.; European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18: 2180-8.
17. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63: 65-81.
18. Vrtovsnik F, Queffeulou G, Skhiri H, et al. Simultaneous IgA nephropathy and Wegener's granulomatosis-overlap or coincidence (the role of renal biopsy). Nephrol Dial Transplant 1999; 14: 1266-7. (Pubitemid 29209322)
19. Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal history, therapy and renal outcome. Clin Nephrol 1991; 35: 139-47.
20. Brouwer E, Huitema MG, Mulder AH, et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994; 45: 1120-31. (Pubitemid 24234730)
21. Grotz W, Wanner C, Keller E, et al. Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome. Clin Nephrol 1991; 35: 243-51.
22. Ronco P, Verroust P, Mignon F, et al. Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies. Q J Med 1983; 52: 212-23. (Pubitemid 14248295)
23. Hu CH, O'Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener granulomatosis. Arch Dermatol 1977; 113: 175-82.
24. Pinching AJ, Lockwood CM, Pussell BA, et al. Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med 1983; 52: 435-60.
25. Brouwer E, Huitema MG, Klok PA, et al. Antimyelo-peroxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med 1993; 177: 905-14. (Pubitemid 23097380)
26. Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 2003; 41: 539-49.